Prevalence of Alzheimer's Disease and Parkinson's Disease in China: An Updated Systematical Analysis
- PMID: 33424580
- PMCID: PMC7793643
- DOI: 10.3389/fnagi.2020.603854
Prevalence of Alzheimer's Disease and Parkinson's Disease in China: An Updated Systematical Analysis
Abstract
Background: Alzheimer's disease (AD) and Parkinson's disease (PD) are two major neurodegenerative diseases worldwide. Demographic aging is in rapid progress in China. Up-to-date estimates of AD and PD prevalence have not been provided. Methods: Studies that reported the prevalence of AD and PD in China were identified via a systematic database search from 1985 to 2018. Meta-analysis, local polynomial regression and autoregressive integrated moving average model were used for analyses. Results: A total of 99 studies were included in the study with populations of 385,312 and 227,228, respectively for AD and PD. The overall prevalence of AD and PD following age standardization was 3.20% [95% confidence interval (CI) = 3.17-3.23] and 1.06% (95% CI = 1.02-1.10), respectively in individuals over 60 years old. The rates increased drastically for every 10-years increment of age. The yearly prevalence of AD was predicted to increase from 3.81 to 6.17% in the next 5 years. Significant differences were observed between genders [male to female odds ratio (OR) for AD = 0.57, 95% CI = 0.51-0.64; OR for PD = 1.25, 95% CI = 1.06-1.46], and between education levels (Illiterate to non-illiterate OR for AD = 2.99, 95% CI = 2.38-3.75), but not between urban and rural settings. Conclusion: Our results provide an updated insight into the epidemiology of AD and PD in China and their associated rates and ratios. The findings may facilitate China policy makers and health professionals mitigate the related health issues.
Keywords: Alzheimer's disease; China; Parkinson's disease; epidemiology; prevalence; systematical analysis.
Copyright © 2020 Cui, Hou, Wu, Zuo, Lian, Zhang, Wang, Zhang and Zhu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures




Similar articles
-
Sex ratio in dementia with Lewy bodies balanced between Alzheimer's disease and Parkinson's disease dementia: a cross-sectional study.Alzheimers Res Ther. 2018 Sep 12;10(1):92. doi: 10.1186/s13195-018-0417-4. Alzheimers Res Ther. 2018. PMID: 30208961 Free PMC article.
-
Association of Intestinal Disorders with Parkinson's Disease and Alzheimer's Disease: A Systematic Review and Meta-Analysis.ACS Chem Neurosci. 2020 Feb 5;11(3):395-405. doi: 10.1021/acschemneuro.9b00607. Epub 2020 Jan 8. ACS Chem Neurosci. 2020. PMID: 31876406
-
The Occurrence of Alzheimer's Disease and Parkinson's Disease in Individuals With Osteoporosis: A Longitudinal Follow-Up Study Using a National Health Screening Database in Korea.Front Aging Neurosci. 2021 Dec 8;13:786337. doi: 10.3389/fnagi.2021.786337. eCollection 2021. Front Aging Neurosci. 2021. PMID: 34955816 Free PMC article.
-
The Association of Pre-existing Diagnoses of Alzheimer's Disease and Parkinson's Disease and Coronavirus Disease 2019 Infection, Severity and Mortality: Results From the Korean National Health Insurance Database.Front Aging Neurosci. 2022 Mar 3;14:821235. doi: 10.3389/fnagi.2022.821235. eCollection 2022. Front Aging Neurosci. 2022. PMID: 35317529 Free PMC article.
-
Occupational Exposures and Neurodegenerative Diseases-A Systematic Literature Review and Meta-Analyses.Int J Environ Res Public Health. 2019 Jan 26;16(3):337. doi: 10.3390/ijerph16030337. Int J Environ Res Public Health. 2019. PMID: 30691095 Free PMC article.
Cited by
-
Nanoparticle-Based Activatable MRI Probes for Disease Imaging and Monitoring.Chem Biomed Imaging. 2023 Mar 29;1(3):192-204. doi: 10.1021/cbmi.3c00024. eCollection 2023 Jun 26. Chem Biomed Imaging. 2023. PMID: 39473694 Free PMC article. Review.
-
Herbal medicines in Alzheimer's disease and the involvement of gut microbiota.Front Pharmacol. 2024 Jul 16;15:1416502. doi: 10.3389/fphar.2024.1416502. eCollection 2024. Front Pharmacol. 2024. PMID: 39081953 Free PMC article. Review.
-
Cerebroprotein hydrolysate attenuates neurodegenerative changes in Alzheimer's mice model via ferroptosis pathway.Front Pharmacol. 2023 Apr 19;14:1177503. doi: 10.3389/fphar.2023.1177503. eCollection 2023. Front Pharmacol. 2023. PMID: 37153800 Free PMC article.
-
Independent component analysis of oddball EEG recordings to detect Parkinson's disease.Sci Rep. 2025 Jul 1;15(1):21889. doi: 10.1038/s41598-025-07645-8. Sci Rep. 2025. PMID: 40594683 Free PMC article.
-
Targeting Oxidative Stress: Novel Coumarin-Based Inverse Agonists of GPR55.Int J Mol Sci. 2021 Oct 28;22(21):11665. doi: 10.3390/ijms222111665. Int J Mol Sci. 2021. PMID: 34769094 Free PMC article.
References
-
- Chow N. (2006). The practice of filial piety and its impact on long-term care policies for elderly people in Asian Chinese communities. Asian J. Gerontol. Geriatr. 1, 31–35. Available online at: http://ajgg.org/image/module/ajgg_issue/1/31-T6.pdf
LinkOut - more resources
Full Text Sources
Medical